Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
| Actual shortage: | 229 (8%) | |
| Anticipated shortage: | 14 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2786 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-06-17 | 2022-07-28 | 162904 |
| APO-LEVOFLOXACIN | 750MG | TABLET | Resolved | 2022-06-17 | 2022-07-28 | 162907 |
| APO-DASATINIB | 100MG | TABLET | Resolved | 2022-06-17 | 2022-07-19 | 162910 |
| APO-ENALAPRIL | 10MG | TABLET | Resolved | 2022-06-17 | 2022-06-30 | 162913 |
| APO-AMOXI | 250MG | POWDER FOR SUSPENSION | Resolved | 2022-06-17 | 2024-02-14 | 162918 |
| APO-FLECAINIDE | 50MG | TABLET | Resolved | 2022-06-27 | 2022-09-06 | 163445 |
| APO-LEVETIRACETAM | 500MG | TABLET | Resolved | 2022-06-27 | 2022-08-24 | 163448 |
| APO-MIRTAZAPINE | 15MG | TABLET | Resolved | 2022-06-27 | 2022-08-12 | 163453 |
| APO-FROVATRIPTAN | 2.5MG | TABLET | Resolved | 2022-06-30 | 2022-09-02 | 163722 |
| APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2022-07-05 | 2022-10-31 | 164083 |
| APO-TRAZODONE TABLETS 50MG | 50MG | TABLET | Resolved | 2022-07-05 | 2022-09-01 | 164086 |
| APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Resolved | 2022-07-11 | 2022-09-01 | 164364 |
| APO-CITALOPRAM | 40MG | TABLET | Resolved | 2022-07-11 | 2022-08-22 | 164367 |
| APO-ALENDRONATE | 70MG | TABLET | Resolved | 2022-07-11 | 2022-08-11 | 164370 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2022-07-11 | 2022-08-19 | 164373 |
| APO-GUANFACINE XR | 1MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-07-11 | 2022-08-12 | 164378 |
| APO-FAMCICLOVIR | 250MG | TABLET | Resolved | 2022-07-15 | 2022-09-23 | 164701 |
| APO-LEVETIRACETAM | 250MG | TABLET | Resolved | 2022-07-15 | 2022-08-24 | 164710 |
| APO-LEVOFLOXACIN | 250MG | TABLET | Resolved | 2022-07-15 | 2023-01-20 | 164719 |
| APO-LEVOFLOXACIN | 500MG | TABLET | Resolved | 2022-07-15 | 2022-08-06 | 164728 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-AMOXI SUGAR FREE | 250MG | POWDER FOR SUSPENSION | Discontinued | 2020-06-22 | 2020-06-22 | 118526 |
| APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 119950 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2021-06-25 | 2021-06-25 | 141546 |
| APO-PINDOL TAB 5MG | 5MG | TABLET | Discontinued | 2022-02-09 | 2022-02-10 | 154568 |
| APO-PINDOL TAB 10MG | 10MG | TABLET | Discontinued | 2022-02-09 | 2022-02-10 | 154571 |
| APO-PINDOL TAB 15MG | 15MG | TABLET | Discontinued | 2022-02-09 | 2022-12-09 | 154574 |
| MELPHALAN FOR INJECTION | 10ML 50MG | POWDER FOR SOLUTION KIT SOLUTION | Discontinued | 2022-03-23 | 2022-03-23 | 157136 |
| APO-BICALUTAMIDE | 50MG | TABLET | Discontinued | 2022-03-25 | 2022-05-13 | 157376 |
| APO-CLOBETASOL SPRAY | 0.05% | SPRAY | Discontinued | 2022-09-06 | 2022-09-06 | 168648 |
| APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE | 300MG 150MG 300MG | TABLET | Discontinued | 2022-12-12 | 2022-12-12 | 177953 |
| APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Discontinued | 2023-09-26 | 2023-11-02 | 205310 |
| APO-CARVEDILOL | 12.5MG | TABLET | To be discontinued | 2024-01-26 | 2024-04-01 | 217493 |
| APO-CARVEDILOL | 3.125MG | TABLET | To be discontinued | 2024-01-26 | 2024-01-26 | 217496 |
| APO-CARVEDILOL | 6.25MG | TABLET | To be discontinued | 2024-01-26 | 2024-01-26 | 217499 |
| APO-CARVEDILOL | 25MG | TABLET | Discontinued | 2024-01-26 | 2024-01-27 | 217504 |